Skip to content
← Back to this collection

PUBLICATIONS · 21747090

Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2011 Aug 10
First author
Hof J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hof J
      type
      Author
    2. name
      Krentz S
      type
      Author
    3. name
      van Schewick C
      type
      Author
    4. name
      Körner G
      type
      Author
    5. name
      Shalapour S
      type
      Author
    6. name
      Rhein P
      type
      Author
    7. name
      Karawajew L
      type
      Author
    8. name
      Ludwig WD
      type
      Author
    9. name
      Seeger K
      type
      Author
    10. name
      Henze G
      type
      Author
    11. name
      von Stackelberg A
      type
      Author
    12. name
      Hagemeier C
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hof J
      type
      Author
    2. name
      Krentz S
      type
      Author
    3. name
      van Schewick C
      type
      Author
    4. name
      Körner G
      type
      Author
    5. name
      Shalapour S
      type
      Author
    6. name
      Rhein P
      type
      Author
    7. name
      Karawajew L
      type
      Author
    8. name
      Ludwig WD
      type
      Author
    9. name
      Seeger K
      type
      Author
    10. name
      Henze G
      type
      Author
    11. name
      von Stackelberg A
      type
      Author
    12. name
      Hagemeier C
      type
      Author
    bibliography ids
    1. nci-bib-162d82fc4f6202779d27f5dc
    book metadata
    content sha256
    45b53dfc0ac41ce912be3b35b08e35b8186d7142e0a07e1077da8e077b91fe18
    document type
    citation
    dois
    1. 10.1200/JCO.2011.34.8144
    electronic publication date
    display
    2011 Jul 11
    precision
    day
    year
    2011
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21747090
    immutable id
    pubmed:21747090@45b53dfc0ac41ce912be3b35b08e35b8186d7142e0a07e1077da8e077b91fe18
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    23
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3185-93
    volume
    29
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21747090
      provenance
      batch id
      2529ef2eca926738ab13
      provider
      NCBI PubMed ESummary
      record sha256
      25ee08ea25f85949679f3cc6d5c79113a8cd83ba84cbfb459f82374eb55edd21
      response sha256
      9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
      retrieved at
      2026-09-09T23:46:42.856296+00:00
      publication date
      display
      2011 Aug 10
      precision
      day
      year
      2011
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21747090/
      title
      Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.

      Preserved source evidence · Not medical advice